Non-pharmaceutical treatment combats recurring Clostridium Difficile infections
Transplanting human donor fecal microbiota into the colon of a patient infected with Clostridiodes difficile (C. diff) may be the best treatment for those not helped by C. diff targeted antibiotics, according to an article in the Journal of the American Osteopathic Association.
C. diff is the most common healthcare-acquired infection in the United States. It affects nearly half a million patients each year and becomes a recurring infection for nearly a third of them. If untreated, C. diff can lead to sepsis and death.
“Twenty five years ago C. diff infections were easier to manage and often resolved with discontinuation of the initiating antibiotic,” says Robert Orenstein, DO, an infectious disease specialist at Mayo Clinic and lead author on this article. “However, these infections have become increasingly common and pernicious.”
The standard and FDA-approved treatment for C. diff is a course of oral vancomycin, an antibiotic. However, even the medications used to eliminate C. diff can perpetuate the infection by killing off beneficial microbes. Newer antibiotics that more specifically target C. diff have been developed but they can be prohibitively expensive, according to Dr. Orenstein.
“Think of your gut as a forest and C. diff as a weed,” says Dr. Orenstein. “In a thriving forest, weeds barely get a foothold. But if you burn the forest down, the weeds are going to flourish.”
Unlike antibiotics, which are destructive by definition, fecal transplants or microbial replacement therapies, repopulate the gut with a diverse group of microbes that may block the C. diff‘s spore from germinating and propagating disease via its toxins. Transplants have several delivery methods, including enemas, capsules and direct instillation, to replace the diverse flora that maintain health and improve metabolism.
Currently, there are no FDA-approved fecal transplant products and performing fecal transplants is considered an investigational procedure. Dr. Orenstein notes there are several companies with products in Phase 3 clinical trials that could come to market as early as 2020. For this reason he strongly urges healthcare providers to refer patients with recurrent C. diff for these trials rather than for fecal transplants. In the meantime, the FDA reserves fecal transplants for patients who have experienced a second recurrence (third episode) of C. diff infection.
C. diff is common in healthcare settings and public spaces and rarely causes problems in people with healthy gut microbiota and immune systems, according to researchers. However, people who are already ill and taking antibiotics, chemotherapy, or proton pump inhibitors–which all greatly disrupt the gut ecosystem–are at risk. Elderly patients are especially vulnerable.
Dr. Orenstein expects the new treatment options will improve outcomes but says physicians need to assume greater responsibility for prevention.
“One of the most effective things physicians can do is become more responsible with antibiotic prescriptions,” says Dr. Orenstein. “That means only prescribing when they are clearly indicated, not for colds or viral sinus infections. We also must be especially judicious with elderly patients.”
Learn more: Mayo Clinic doctors: Fecal transplants may be best answer to antibiotic-resistant bacteria
The Latest on: Fecal transplants
[google_news title=”” keyword=”fecal transplants” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Fecal transplants
- Microbiota Therapeutics Could Become Strong Ally in IBD Treatmenton May 2, 2024 at 5:00 pm
Microbiota therapeutics, such as fecal microbiota transplantation (FMT), could offer more diverse, personalized treatment options for patients with inflammatory bowel disease (IBD), particularly for ...
- Prospects for Crohn's Relief Brighten With New Advancementson May 2, 2024 at 1:39 pm
More than 1 million Americans live with Crohn’s, a chronic and sometimes crippling bowel disease that affects the intestines and leads to digestive issues. But in 2024, breakthroughs could bring ...
- Fecal Transplant Shows Promise for Easing Inflammatory Bowel Disease Symptomson April 25, 2024 at 4:45 pm
For the study, scientists reviewed results from 15 clinical trials that tested fecal microbiota transplants (FMT) — when stool with healthy microorganisms is inserted into a sick patient’s digestive ...
- Researchers conclude fecal transplants can rid patients of resistant gut bacteriaon April 15, 2024 at 5:00 pm
Fecal transplantation suppresses or even eliminates the abundance of resistant bacteria that patients possess. This protection is expected to last for the longer term. In the study, patients were ...
- Fecal transplants and gut health - Can stool heal?on April 12, 2024 at 5:00 pm
A new medical approach that smells bad, but is full of promise: fecal transplantation. The process involves taking stool from a healthy donor and implanting it into the gut of a sick individual.
- Stool transplant could improve motor symptoms in Parkinson’s diseaseon April 12, 2024 at 5:00 pm
A recent paper has highlighted the potential effect of fecal transplants on motor symptoms, which are one of the main markers of Parkinson’s disease. The study could pave the way for further ...
- Examining the Potential of Fecal Transplantation as a Parkinson’s Disease Treatmenton April 8, 2024 at 10:05 pm
Conclusion Fecal microbiota transplantation shows significant promise as a novel therapeutic option for early stage Parkinson’s disease patients. The potential for motor symptom improvement and ...
- Researchers Conduct First Fecal Microbiota Transplant in Dolphinson March 24, 2024 at 5:00 pm
The paper is the first of its kind to describe the use of fecal microbiota transplants (FMTs) in dolphins in peer-reviewed literature. Prior to this work, there were only a handful of anecdotal cases ...
- Fecal microbiota transplants: Past, present and futureon February 9, 2024 at 11:30 am
The premise of fecal microbiota transplants (FMT) is, admittedly, not the most pleasant. The process involves transferring donor stool (or derivatives thereof) to a recipient for a therapeutic purpose ...
- Fecal Microbiota Transplants: From Gut Infections to Psychiatric Disorderson July 26, 2023 at 8:54 am
Fecal transplantation is an established procedure for controlling recurrent Clostridium difficile infection by replenishing healthy bacteria in the gut. Researchers explore novel applications of fecal ...
via Bing News